Effect of Hemopoietic Growth Factors G-CSF and pIXY 321 on the Activity of High Dose ARA-C in Human Myeloid Leukemia Cells

References

• Bolwell B. J, Cassileth P. A., Gale R. P. High dose cytarabine: A review. Leukemia 1988; 2: 253–260
   PubMed Web of Science ®Google Scholar
• Chabner B. A. Cytosine arabinoside. Pharma-cologic Principles of Cancer Treatment, B. A. Chabner. W.B. Saunders. 1990; 387–701
   Google Scholar
• Raza A., Preisler H. D., Day R., Yasin Z., White M., Lykins J., Kukla C., Barcos M., Bennett J., Browman G., Goldberg J., Grimwald H., Larson R., Vardiman J., Vogler R. Direct relationship between remission duration in acute myeloid leukemia and cell cycle kinetics: A leukemia intergroup study. Blood 1990; 76: 2191–2197
   PubMed Web of Science ®Google Scholar
• Breithaupt H., Pralle H., Eckhardt T., Von Hattingberg M., Schick J., Loffler H. Clinical results and pharmacokinetics of high dose cytosine arabinoside. Cancer 1982; 50: 1248–1257
   PubMed Web of Science ®Google Scholar
• White J. C., Rathmell J. P., Capizzi R. L. Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells. J. Clin. In-vest. 1987; 79: 380–387
   PubMed Web of Science ®Google Scholar
• Plunkett W., Liliemark J. O., Estey E., Keating M. J. Saturation of Ara-CTP accumulation during high-dose ara-c therapy: Pharmacologic rationale for intermediate-dose ara-C. Semin. Oncol. 1987; 14: 159–166
   PubMed Web of Science ®Google Scholar
• Kufe D. W., Spriggs D. R. Biochemical and cellular pharmacology of cytosine arabinoside. Sem. Oncol. 1985; 12(Suppl 3)34–48
   PubMedGoogle Scholar
• Damon L. E., Plunkett W., Linker C. A. Plasma and cerebrospinal fluid pharmacokinetics of 1-β-D-Arabinofuranosylcytosine and l-β-Arabinofuranosyluracil following the repeated intravenous administration of high-and intermediate-dose 1-β-D-Arabinofuranosylcytosine. Cancer Research 1991; 51: 4141–4145
   PubMed Web of Science ®Google Scholar
• Metcalf D. Control of granulocytes and macro-phages: molecular, cellular and clinical aspects. Science 1991; 254: 529–533
   PubMed Web of Science ®Google Scholar
• Williams G. T., Smith C. A., Spooncer E., Dexter T. M., Taylor D. R. Hemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 1990; 343: 76–79
   PubMed Web of Science ®Google Scholar
• Williams D. E., Park L. S. Hematopoietic effects of a granulocyte-macrophage colony stimulating factor/ Interluekin-3 fusion protein. Cancer 1991; 67: 2705–2707
   PubMed Web of Science ®Google Scholar
• Demetri G. D., Griffin J. D. Granulocyte colony stimulating factor and its receptor. Blood 1991; 78: 2791–2808
   PubMed Web of Science ®Google Scholar
• Tafuri A., Andreeff M. Kinetic rationale for cytokine induced recruitment of myeloblastic leukemia followed by cycle specific chemotherapy in vitro. Leukemia 1990; 4: 826–834
   PubMed Web of Science ®Google Scholar
• Cannistra S. A., Groshek P., Griffin J. D. Granulocyte macrophage colony stimulating factor enhances the cytotoxic effect of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia. Leukemia 1989; 3: 328–334
   PubMed Web of Science ®Google Scholar
• Brach M., Klein H., Platzer E., Mertelsmann R., Herrman F. Effect of Interleukin-3 on cytosine arabinoside mediated cytotoxicity of leukemic myeloblasts. Exp. Hematol. 1990; 18: 748–753
   PubMed Web of Science ®Google Scholar
• Karp J. E., Burke P. J., Donehower R. C. Effects of rGM-CSF on intracellular Ara-C pharmacology in vitro in acute myelocytic leukemia: Comparability with drug induced humoral stimulatory activity. Leukemia 1990; 4: 553–556
   PubMed Web of Science ®Google Scholar
• Bhalla K., Holladay C., Arlin Z., Grant S., Ibrado A. M., Jasiok M. Treatment with IL-3 plus GM-CSF improves the selectivity of Ara-C in vitro against AML blasts. Blood 1991; 78: 2674–2679
   PubMed Web of Science ®Google Scholar
• Bettelheim P., Valent P., Andreeff M., Tafuri A., Haimi J., Gorischek C., Muhm M., Sillaber C., Haas O., Vieder L., Maurer D., Schultz G., Speiser W., Geissler K., Kier P., Hinterberger W., Lechner K. Re-combinant granulocyte macrophage colony stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia. Blood 1991; 77: 700–711
   PubMed Web of Science ®Google Scholar
• Gunji H., Kharbanda S., Kufe D. Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-β-D-arabinofuranosylcytosine. Cancer Res. 1991; 51: 741–743
   PubMed Web of Science ®Google Scholar
• Kharbanda S., Datta R., Kufe D. Regulation of c-jun gene expression in HL-60 leukemic cells by 1-β-D-Arabinofuranoslyctosine: Potential involvement of a protein kinase C dependent mechanism. Biochem. 1991; 30: 7947–7952
   PubMed Web of Science ®Google Scholar
• Brach M. A., Herrmann F., Kufe D. W. Activation of the AP-1 transcription factor by arabinofurano-sylcytosine in myeloid leukemia cells. Blood 1992; 79: 728–734
   PubMed Web of Science ®Google Scholar
• Lubbert M., Herrmann F., Koeffler H. P. Expression and regulation of myeloid-specific genes in normal and leukemia myeloid cells. Blood 1991; 77: 909–924
   PubMed Web of Science ®Google Scholar
• Bhalla K., Nayak R., Grant S. Isolation and characterization of a deoxycytidine kinase-deficient, human promyelocytic leukemic cell line highly resistant to 1-B-D-arabinofuranosylcytosine. Cancer Res. 1984; 44: 5029–5036
   PubMed Web of Science ®Google Scholar
• Kyprianou N., Isaacs J. T. Thymineless death in androgen independent prostatic cancer cells. Biochem. Biophys. Res. Comm. 1989; 165: 73–81
   PubMed Web of Science ®Google Scholar
• Chirgwin J., Przbyla H., McDonald R., Rutter W. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294–5299
   PubMed Web of Science ®Google Scholar
• Thomas P. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Pro. Natl. Acad. Sci. U.S.A. 1980; 77: 5201–5205
   PubMed Web of Science ®Google Scholar
• Garrett C., Santi D. V. A rapid and sensitive high pressure liquid chromatographic assay for deoxyribon-ucleotide triphosphate in cell extracts. Annal Biochem. 1979; 99: 268
   PubMed Web of Science ®Google Scholar
• Martin S. J., Bradley J. G., Cotter T. G. HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin. Exp. Immunol. 1990; 79: 448–453
   PubMed Web of Science ®Google Scholar
• Hockenbery D., Numez G., Millimen C., Schreiber R. D., Korsmeyer S. J. BCL-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334–336
   PubMed Web of Science ®Google Scholar
• Tritton T. R. Cell death in cancer chemotherapy: the case of adriamycin. Apoptosis: the molecular basis of cell death, L. D. Tomei, F. O. Cope. Cold Spring Harbor Laboratory Press. 1991; 121–137
   Google Scholar
• Barry M. A., Behnke C. A., Eastman A. Activation of programmed cell death (Apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol. 1990; 40: 2353
   PubMed Web of Science ®Google Scholar
• Kharbanda S., Rubiu E., Gunji H., Hinz H., Giova-nella G., Pantazis P., Kufe D. Camptothecin and its derivates induce expression of the c-jun proto-on-cogene in human myeloid leukemia cells. Cancer Res. 1991; 51: 6636–6642
   PubMed Web of Science ®Google Scholar
• Waring P., Kos F. J., Mullbacher A. Apoptosis or programmed cell death. Med. Res. Rev. 1991; 11: 219–236
   PubMed Web of Science ®Google Scholar
• Arends M. J., Morris R. G., Wyllie A. H. Apoptosis: the role of the endonuclease. Am. J. Pathol. 1990; 136: 593–608
   PubMed Web of Science ®Google Scholar
• Wyllie A. H. Apoptosis: cell death in tissue regulation. J. Pathol. 1987; 153: 313
   PubMed Web of Science ®Google Scholar
• Kanakura Y., Druker B., Wood K. W., Matnon H. J., Okuda K. T. M., Griffin J. D. Granulocyte macrophage colony stimulating factor and Interleukin-3 induce rapid phosphorylation and activation of the proto-on-cogene raf-1 in a human factor dependent myeloid cell line. Blood 1991; 77: 243–248
   PubMed Web of Science ®Google Scholar
• Veis N., Hamilton J. A. GM-CSF and IL-3 stimulate diaclyglycerol generation in murine bone marrow derived macrophages. Biochem. Biophys. Res. Comm. 1991; 179: 586–589
   PubMed Web of Science ®Google Scholar
• Farrar W. L., Thomas T. P., Anderson W. B. Altered cytosol/membrane enzyme redistribution on Interleukin-3 activation of protein kinase C. Nature 1985; 315: 235
   PubMed Web of Science ®Google Scholar
• Grant S., Boise L., Westin E., Howe C., Pettit G. R., Turner A., McCrady C. In vitro effects of bryo-statin-1 on the metabolism and cytotoxicity of 1-B-D-ara-binofuranosylcytosine in human leukemia cells. Biochem. Pharmacol. 1991; 42: 853–867
   PubMed Web of Science ®Google Scholar
• Alnemri E. S., Fernandes T. F., Haldar S., Croce C. M., Litwack G. Involvement of BCL-2 in glucocor-ticoid-induced apoptosis in human pre-B-leukemias. Cancer Res. 1992; 52: 491–495
   PubMed Web of Science ®Google Scholar
• Walton M. I., Whysong D., O'Connor P. M., Korsmeyer S. J., Hockenberry D., Kohn K. W. Constitutive expression of BCL-2 in murine lymphocytes imparts partial protection to DNA damage induced apoptosis. Proc. Amer. Assoc. Cancer. Res. 1992; 33: 897
   Google Scholar
• Kastan M. B., Radin A. I., Kuerbitz S. J., Onyekwere O., Wolkow C. A., Civin C. I., Stone K. D., Woo T., Ravindranath Y., Craig R. W. Level of p53 protein increase with maturation in human hematopoietic cells. Cancer Res. 1991; 51: 4279–4286
   PubMed Web of Science ®Google Scholar
• Yonish-Rouach E., Resnitzky D., Lotem J., Sachs L., Kimchi A., Oren M. Wild type p53 induces apoptosis of myeloid leukemic cells that is inhibited by in-terleukin-6. Nature 1991; 353: 345–347
   Web of Science ®Google Scholar